Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Share News (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes
Get Live Data
43.50    -1.50 (-3.33%)
Bid:
42.00
Ask:
45.00
Spread: 3.00 (7.143%)
Market Cap: £86.79m
FARN Live PriceLast checked at - London Stock Exchange

Intraday Faron Pharmaceuticals Share Chart

Faron Pharmaceuticals Notes Study Supporting Clevegen Programme

Mon, 30th Nov 2015 09:35

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said an article published in the Journal of Immunology has outlined the functional role of the company's Clever-1 treatment, part of its Clevegen cancer immunotherapy antibody programme.

Faron, which floated in London earlier this month, said the data published in the study supported Clever-1 as an immuosuppresive molecule and supports the use of Clevegen as an immunotherapy product.

"We are working hard to advance our Clevegen programme, as announced recently, towards clinical use as a new onco-immunological alternative," said Faron Chief Executive Markku Jalkanen.

Shares in Faron were trading flat at 275.00 pence on Monday.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2015 Alliance News Limited. All Rights Reserved.

Related News

IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki
4 days ago

IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki

Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,0...

WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake
14 Apr 2026

WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.

Faron Pharmaceuticals News

Faron Pharmaceuticals Falls As Interim Loss Widens On Research Costs
13 Sep 2018

Faron Pharmaceuticals Falls As Interim Loss Widens On Research Costs

LONDON (Alliance News) - Shares in Faron Pharmaceuticals Ltd dropped on Thursday after the company said its loss for the first half of its financial y...

Faron losses widen following disappointing Traumakine trial
13 Sep 2018

Faron losses widen following disappointing Traumakine trial

(Sharecast News) - Faron Pharmaceuticals' operating loss doubled in the first half of its trading year following the group's disappointing trial on it...

Faron Pharmaceuticals Says New Clever-1 Data Shows B Cell Response
12 Sep 2018

Faron Pharmaceuticals Says New Clever-1 Data Shows B Cell Response

LONDON (Alliance News) - Faron Pharmaceuticals Ltd said Wednesday that new data from its cell surface receptor Clever-1 showed B cell response control...

UK Earnings, Trading Statements Calendar - Next 7 Days
6 Sep 2018

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 7 September Secure Income REITHalf Year Results Ashmore GroupFull Year Year

DIRECTOR DEALINGS: Faron Pharmaceuticals Directors Buy Shares
21 Jun 2018

DIRECTOR DEALINGS: Faron Pharmaceuticals Directors Buy Shares

LONDON (Alliance News) - Faron Pharmaceuticals Oy said on Thursday several directors purchased shares over the course of three days from Tuesday to Th...

Faron Pharmaceutics Reports Inconsistent Traumakine Biomarker Results
14 Jun 2018

Faron Pharmaceutics Reports Inconsistent Traumakine Biomarker Results

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Thursday said preliminary biomarker data from its Traumakine phase III trial has produced inconsi...

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts
14 Jun 2018

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2....

UK Shareholder Meetings Calendar - Next 7 Days
24 May 2018

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of